Anika Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Anika Therapeutics, Inc. (ANIK) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.30% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2016-03-10
- Anika Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2015 was -0.30%, a 400.00% decline from fiscal 2014.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was 0.10%.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2013 was -0.20%, a 122.22% decline from fiscal 2012.
- Anika Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2012 was 0.90%, a 0.00% change from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2015-12-31 | -0.30% 10-K · filed 2016-03-10 |
| 2014-12-31 | 0.10% 10-K · filed 2016-03-10 |
| 2013-12-31 | -0.20% 10-K · filed 2016-03-10 |
| 2012-12-31 | 0.90% 10-K · filed 2015-03-13 |
| 2011-12-31 | 0.90% 10-K · filed 2014-03-13 |
| 2010-12-31 | 2.20% 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |